Evaluation of the efficacy of adding Domperidone for the treatment of refractory gastroesophageal reflux disease
Not Applicable
- Conditions
- Gastro-oesophageal reflux disease.Gastro-oesophageal reflux disease
- Registration Number
- IRCT2017052134070N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with gastroesophageal reflux disease that do not partially or completely respond to treatment after taking twice daily proton pump inhibitor for one month
Exclusion criteria: age below 18 or above 80 years; severe cardiopulmonary, renal or liver failure; pregnancy; breast feeding; history of gastro-esophageal surgery or malignancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to treatment. Timepoint: One month after starting therapy. Method of measurement: questionnnaires.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: One month after starting tratment. Method of measurement: Questionnaire.